NCT01335347View on ClinicalTrials.gov

Safety Study of an Oral Vaccine to Prevent Avian Influenza

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

September 30, 2012

Conditions
Avian InfluenzaBird Flu
Interventions
BIOLOGICAL

ND1.1

adenovirus with the dsRNA adjuvant, dried and put into capsules

BIOLOGICAL

Placebo control

Capsules of the same size and shape as experimental groups

Trial Locations (1)

Unknown

San Diego

Sponsors

Lead Sponsor

Vaxart
All Listed Sponsors
lead

Vaxart

INDUSTRY

NCT01335347 - Safety Study of an Oral Vaccine to Prevent Avian Influenza | Biotech Hunter | Biotech Hunter